Literature DB >> 22217712

Ascorbate depletion increases growth and metastasis of melanoma cells in vitamin C deficient mice.

J Cha1, M W Roomi, V Ivanov, T Kalinovsky, A Niedzwiecki, M Rath.   

Abstract

AIM: Our main objective was to determine the effect of ascorbate supplementation in mice unable to synthesize ascorbic acid (gulo KO) when challenged with murine B16FO cancer cells.
METHODS: Gulo KO female mice 36-40 weeks of age were deprived of or maintained on ascorbate in food and water for 4 weeks prior to subcutaneous injection of 2.5×10(6) B16FO murine melanoma cells in the right flank of mice. A control group of wild type mice were also injected with the melanoma cells and maintained on a regular murine diet. Mice were continued on their respective diets for another 2 weeks after injection. The mice were then sacrificed, blood was drawn and their tumors were measured, excised and processed for histology.
RESULTS: Mean weight of animals decreased significantly (30%, p < 0.0001) in the ascorbate-restricted group but increased slightly, but insignificantly, in the ascorbate-supplemented group. The mean tumor weight in ascorbate supplemented mice was significantly reduced (by 64%, p = 0.004) compared to tumor weight in ascorbate-deprived gulo mice. The mean tumor weight of wild type mice did not differ significantly from the ascorbate-supplemented mice. Gulo KO mice supplemented with ascorbate developed smaller tumors with more collagen encapsulation and fibrous capsule interdigitation, while gulo KO mice deprived of ascorbate hosted large tumors with poorly defined borders, showing more necrosis and mitosis. Ascorbate supplementation of gulo KO mice resulted in profoundly decreased serum inflammatory cytokine IL-6 (90% decrease, p = 0.04) and IL-1β (62% decrease) compared to the levels in gulo KO mice deprived of ascorbate.
CONCLUSION: Ascorbate supplementation modulated tumor growth and inflammatory cytokine secretion as well as enhanced encapsulation of tumors in scorbutic mice.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22217712

Source DB:  PubMed          Journal:  Exp Oncol        ISSN: 1812-9269


  14 in total

Review 1.  Molecular mechanisms of pharmacological doses of ascorbate on cancer cells.

Authors:  Sascha Venturelli; Tobias W Sinnberg; Heike Niessner; Christian Busch
Journal:  Wien Med Wochenschr       Date:  2015-06-12

Review 2.  High-Dose Vitamin C for Cancer Therapy.

Authors:  Ali Mussa; Ros Akmal Mohd Idris; Naveed Ahmed; Suhana Ahmad; Ahmad Hafiz Murtadha; Tengku Ahmad Damitri Al Astani Tengku Din; Chan Yean Yean; Wan Faiziah Wan Abdul Rahman; Norhafiza Mat Lazim; Vuk Uskoković; Khalid Hajissa; Noor Fatmawati Mokhtar; Rohimah Mohamud; Rosline Hassan
Journal:  Pharmaceuticals (Basel)       Date:  2022-06-03

Review 3.  Vitamin C in disease prevention and cure: an overview.

Authors:  Shailja Chambial; Shailendra Dwivedi; Kamla Kant Shukla; Placheril J John; Praveen Sharma
Journal:  Indian J Clin Biochem       Date:  2013-09-01

Review 4.  The epigenetic role of vitamin C in health and disease.

Authors:  Vladimir Camarena; Gaofeng Wang
Journal:  Cell Mol Life Sci       Date:  2016-02-04       Impact factor: 9.261

5.  Epigenetic reprogramming of melanoma cells by vitamin C treatment.

Authors:  Christopher B Gustafson; Cuixia Yang; Kevin M Dickson; Hongwei Shao; Derek Van Booven; J William Harbour; Zhao-Jun Liu; Gaofeng Wang
Journal:  Clin Epigenetics       Date:  2015-04-29       Impact factor: 6.551

Review 6.  Ascorbate as a co-factor for fe- and 2-oxoglutarate dependent dioxygenases: physiological activity in tumor growth and progression.

Authors:  Caroline Kuiper; Margreet C M Vissers
Journal:  Front Oncol       Date:  2014-12-10       Impact factor: 6.244

Review 7.  Current limitations of murine models in oncology for ascorbate research.

Authors:  Elizabeth J Campbell; Gabi U Dachs
Journal:  Front Oncol       Date:  2014-10-14       Impact factor: 6.244

8.  Ascorbate supplementation inhibits growth and metastasis of B16FO melanoma and 4T1 breast cancer cells in vitamin C-deficient mice.

Authors:  John Cha; M Waheed Roomi; Vadim Ivanov; Tatiana Kalinovsky; Aleksandra Niedzwiecki; Matthias Rath
Journal:  Int J Oncol       Date:  2012-11-21       Impact factor: 5.650

9.  Increased Tumor Ascorbate is Associated with Extended Disease-Free Survival and Decreased Hypoxia-Inducible Factor-1 Activation in Human Colorectal Cancer.

Authors:  Caroline Kuiper; Gabi U Dachs; Delwyn Munn; Margaret J Currie; Bridget A Robinson; John F Pearson; Margreet C M Vissers
Journal:  Front Oncol       Date:  2014-02-04       Impact factor: 6.244

10.  Epigenetic impacts of ascorbate on human metastatic melanoma cells.

Authors:  Sascha Venturelli; Tobias W Sinnberg; Alexander Berger; Seema Noor; Mitchell Paul Levesque; Alexander Böcker; Heike Niessner; Ulrich M Lauer; Michael Bitzer; Claus Garbe; Christian Busch
Journal:  Front Oncol       Date:  2014-08-25       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.